Amgen, Inc. - Comment

Document ID: FDA-2009-D-0573-0007
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 01 2010, at 12:51 PM Eastern Standard Time
Date Posted: February 1 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: December 17 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: February 1 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a88a05
View Document:  View as format xml

View Comment

We are pleased to have the opportunity to offer comments on the Draft Guidance on Addendum to International Conference on Harmonisation S6 (Document ID FDA-2009-D-0573-0001).

Attachments:

Amgen, Inc. - Comment

Title:
Amgen, Inc. - Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 8
Eisai Inc. - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0573-0005

Feb 01,2010 11:59 PM ET
Amgen, Inc. - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0573-0007

Feb 01,2010 11:59 PM ET
sanofi-aventis - Comment
Public Submission    Posted: 02/01/2010     ID: FDA-2009-D-0573-0008

Feb 01,2010 11:59 PM ET
BioMarin Pharmaceutical Inc. - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0573-0011

Feb 01,2010 11:59 PM ET
Lauren Elizabeth Black - Comment
Public Submission    Posted: 02/02/2010     ID: FDA-2009-D-0573-0012

Feb 01,2010 11:59 PM ET